Comparison of the Effectiveness of Minoxidil, Cetirizine 1% and Diclofenac 3% in treatment of androgenic alopecia
Phase 3
Recruiting
- Conditions
- androgenetic alopecia.androgenic alopecia
- Registration Number
- IRCT20190511043547N1
- Lead Sponsor
- Shahid Beheshti University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 54
Inclusion Criteria
18-60 years old men with androgenetic alopecia
No contraindication for topical trreatment
Exclusion Criteria
systemic disease
use of other drug in treatment of androgenic alopecia
other pattern of hair loss
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of hair loss. Timepoint: 0,after 2 and 4 months. Method of measurement: fotofinder.
- Secondary Outcome Measures
Name Time Method